Physician profile
Jason E Edling
NPI 1912983206
$515.82
in general payments reported to CMS, 2019-2025
8 companies · $97.73 in 2025
The $97.73 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $215 · 2023: $18.67 · 2024: $36.50 · 2025: $97.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $137.79 | 2020 | |
| Abbvie INC. | $123.02 | 2019-2023 | Linzess, Viberzi |
| Boston Scientific Corporation | $97.73 | 2025 | General - Therapies |
| Takeda Pharmaceuticals U.S.A., INC. | $54.77 | 2019 | |
| Janssen Biotech, INC. | $41.51 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $36.50 | 2024 | Xarelto |
| Covidien Lp | $12.40 | 2019 | |
| Daiichi Sankyo INC. | $12.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Edling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.